Original release date: December 18, 2023
Access to this course expires on:  November 14, 2026 at 11:59 PM Pacific Time
CME 12

Course Description
This course focuses on recurrent challenges encountered by pathologists in the evaluation of breast lesions and emphasize a practical approach on how to resolve them and the diagnostic interpretation of a variety of breast lesions. Each case discussion will address pitfalls and problems that may arise in the interpretation, the importance of radiologic-pathologic correlation and practical considerations regarding patient management.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Review the diagnostic criteria, differential diagnosis, and management implications of various challenging entities in breast pathology, including spindle cell proliferations, vascular lesions, small glandular proliferations, sclerosing lesions, and spectrum of low-grade neoplasia
• Discuss the diagnostic features of inflammatory and reactive lesions of the breast, emphasize the importance of clinical and radiologic correlation, and appropriate clinical management for these lesions
• Review the histologic features of the spectrum of mucinous lesions, and special histologic subtypes of invasive breast cancers, discuss differential diagnostic considerations, and the clinical significance of the classifications
• Develop a practical approach for the diagnostic evaluation of breast core needle biopsies, recognize histologic features essential in distinguishing diagnostic challenging lesions from their mimickers
• Learn about the applications of diagnostic, prognostic and predictive IHC markers in breast pathology, with emphasis on the interpretation, reporting and possible pitfalls

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Stuart J. Schnitt, MD, Hannah Y. Wen, MD, PhD, Timothy M. D'Alfonso, MD, Mara Rendi, MD, PhD

The following IM coordinator reported no relevant financial relationships: Laura Collins, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.